Michael Goldberg - 09 Mar 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Ankur Dhingra, as attorney-in-fact for Michael Goldberg
Issuer symbol
CDNA
Transactions as of
09 Mar 2022
Transactions value $
-$16,094
Form type
4
Filing time
11 Mar 2022, 16:16:54
Previous filing
10 Feb 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $610 +500 +0.82% $1.22* 61.8K 09 Mar 2022 Direct F1
transaction CDNA Common Stock Sale -$16.7K -500 -0.81% $33.41 61.3K 09 Mar 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Stock Option (right to buy) Options Exercise $0 -500 -4% $0.00 12K 09 Mar 2022 Common Stock 500 $1.22 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.30 to $33.55, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 1/12th of the shares subject to the option vested on August 13, 2017 and the shares subject to the option vested monthly thereafter through July 13, 2018.